Leukocytosis in Mycosis Fungoides
Leukocytosis is not a typical feature of early-stage mycosis fungoides but can occur in advanced disease, particularly in Sézary syndrome or with large cell transformation, and when present, indicates more aggressive disease with worse prognosis.
Blood Involvement in MF Staging
The revised staging system for MF explicitly incorporates blood involvement as a critical prognostic factor 1. According to consensus guidelines, flow cytometry of peripheral blood is recommended for staging, though its necessity in early-stage disease without clinical suspicion of blood involvement remains debatable 2.
When Leukocytosis Occurs:
Advanced Disease Presentations:
- Sézary syndrome (Stage IIIB-IVA): Characterized by erythroderma with significant circulating malignant T cells, where leukocytosis with lymphocytosis is a defining feature 1
- Large cell transformation: Can present with marked leukocytosis, as documented in cases with leukemoid reactions reaching extreme levels (118,000/µL) 3
- Stage IVA disease: Blood involvement (B2 classification) automatically places patients in advanced stage, regardless of skin extent 1
Atypical Presentations:
- Peripheral blood involvement can rarely occur even in limited patch-stage disease (T2), though this is uncommon and associated with altered homing molecule patterns 4
- Concurrent B-cell chronic lymphocytic leukemia can cause leukocytosis independent of MF progression 5
Clinical Implications
Prognostic significance: When leukocytosis represents circulating malignant T cells, it indicates:
- Upstaging to at least Stage IIIB or IVA 1
- More aggressive disease course
- Need for systemic rather than skin-directed therapy alone
Diagnostic workup: Complete blood count with differential is part of standard initial evaluation 2, with flow cytometry indicated when:
- Clinical suspicion of Sézary syndrome exists
- Advanced stage disease (Stage IIB or higher)
- Unexplained lymphocytosis on routine testing
Important Caveats
Leukocytosis does not equal blood involvement: Reactive leukocytosis from infection, inflammation, or concurrent hematologic conditions must be distinguished from true circulating lymphoma cells through flow cytometry and T-cell receptor gene rearrangement studies 5.
Leukemoid reactions: Severe cases with extensive ulceration can develop extreme leukocytosis from reactive causes rather than malignant cell circulation, often associated with sepsis and poor outcomes 3.